We feel it is important that as a firm, we support local charities like the Dr. Susan Love Foundation for Breast Cancer Research.

SANTA MONICA, Calif. (PRWEB)
November 06, 2019

Gumbiner Savett Inc., a full-service public accounting firm in Southern California, dedicated their October 2019 fundraising effort to Breast Cancer Awareness Month, specifically to the Dr. Susan Love Foundation for Breast Cancer Research.

The firm held bake sales throughout the month allowing employees to show off their baking skills and raise money for the foundation. During the course of the month, the firm collected names of employees’ family and friends who are survivors and have fought the disease and honored them at the final bake sale dedicating the fundraising effort to them. The firm will match all proceeds raised.

“We are proud of our people and the enthusiasm that has been created for our Breast Cancer Awareness month,” said Shreedhar Kothari, CPA, Audit and Accounting Shareholder. “We feel it is important that as a firm, we support local charities like the Dr. Susan Love Foundation for Breast Cancer Research.”

This is the fourth year that the accounting firm has dedicated the month of October to the Dr. Susan Love Foundation for Breast Cancer Research. The charity’s mission is to improve the lives of those impacted by breast cancer through education and advocacy. The Foundation drives collaborative, cutting-edge research to bring to light the collateral damage of treatment and seeks ways to diminish it.

“We do the breast cancer research no one else will or can. Charitable donations from organizations such as Gumbiner Savett empower the Foundation’s vision for meaningful research and forging unique partnerships that create the clearest path for making breast cancer a thing of the past,” said Christopher Clinton Conway, CEO, Dr. Susan Love Foundation for Breast Cancer Research. “This year the Dr. Susan Love Foundation for Breast Cancer Research has been recognized as the number one breast cancer organization in the U.S. and a 4-star rating on Charity Navigator for responsible spending.”

About Gumbiner Savett Inc. – http://www.gscpa.com

Gumbiner Savett Inc. is a full-service accounting and consulting firm headquartered in Santa Monica. Founded in 1950, its purpose is to facilitate the achievement of clients’ financial objectives and provide career fulfillment for its employees.

Known for its diverse culture, Gumbiner Savett Inc. is dedicated to being a preeminent assurance, tax and business advisory firm for growth oriented businesses, middle market enterprises and high-net worth individuals in Southern California. In addition to traditional private and public company accounting and tax services, it specializes in general business consulting, estate and trust planning, fraud examination studies, business services and bookkeeping and litigation support.

Gumbiner Savett Inc. is an independent member firm of BKR International.

About Dr. Susan Love Foundation for Breast Cancer Research® – http://www.drsusanloveresearch.org

Dr. Susan Love Foundation for Breast Cancer Research is dedicated to mobilizing a future without breast cancer by igniting visionary, collaborative research, with a distinctive approach to education. The Foundation makes innovative breast cancer research possible by generating bold ideas and enlisting the best experts, both inside and outside the field of cancer research, in order to better understand the complex nature of breast cancer and the experience of those impacted by the disease. Its approach to education reflects an understanding of the patient, the doctor and research advances ensuring that everyone has the knowledge to be their own health advocate.

Share article on social media or email:

A leading practitioner-channel dietary supplement company

A ketogenic diet will help the body become more metabolically flexible and able to efficiently generate energy from the ketones produced.

PALM COAST, Fla. (PRWEB)
November 06, 2019

Designs For Health (DFH) – a leading practitioner-channel dietary supplement company, is using its science-based nutrition philosophy to raise awareness about the critical role of a healthy lifestyle in the prevention of type 2 diabetes, which research suggests can also help reverse its progress. This is very encouraging, especially since 30 million Americans have diabetes, according to the Center for Disease Control and Prevention (CVC).

Low carbohydrate and ketogenic diets are a slam-dunk for type 2 diabetes, assures Certified Nutrition Specialist (CNS) and DFH spokesperson Amy Berger, who suggests that “If you have a condition defined by high blood sugar, one potential solution is self-evident: avoid foods that raise blood sugar the most. For most people, this means refined sugar and sugar in general, but for many it also includes starchy foods that might be generally wholesome and nutritious, but which are simply too high in carbohydrates for people with type 2 diabetes.”

Berger notes that the American Diabetes Association, in a consensus report published in May 2019, acknowledged that, “Reducing overall carbohydrate intake for individuals with diabetes has demonstrated the most evidence for improving glycemia and may be applied in a variety of eating patterns that meet individual needs and preferences.”

Jason Bosley-Smith, MS, LDN, CNS, FDN and Director of Education at Designs for Health (DFH), explains that “If you have been diagnosed with diabetes or if your physician has shared that your blood work indicates a pre-diabetic state, transitioning to a ketogenic diet will reduce high blood sugar levels by lowering the carbohydrates you consume. With less sugar and carbohydrates being introduced into your body, your cells will begin responding better to hormonal signals that help regulate your metabolism,” adding that, “this may help you shift away from insulin resistance – a physiological state where your body is unable to effectively utilize sugar or glucose for energy production.”

As an alternative, Bosley-Smith explains that a ketogenic diet will help the body become more “metabolically flexible” and able to efficiently generate energy from the ketones produced. This insulin resistant state is associated not only with diabetes, but also with weight gain and other complications that accompany it. Research indicates that, while not necessarily the primary goal of a ketogenic diet, many individuals lose weight when they reduce and restrict carbohydrate intake and adopt a keto approach.

For this regime, individuals should focus on low-carb meals featuring non-starchy vegetables, moderate amounts of protein from meats and poultry, and plenty of healthy fats from foods such as olive and coconut oil, fish, and nuts. There are also great keto snack choices that will help curb sweet cravings. DFH recently launched their KTO-360TM product line made with the keto-friendly, next-generation sweetener, Allulose.

There has been progress around the disease nationwide; researchers reported earlier this year that new cases of diagnosed diabetes dropped 35% while no increase was detected in total cases (CVC Report). Part of this is due to increasing awareness, changes in diet and physical activity, as well as diagnostic and screening practices.

About Designs for Health:

Family-owned Designs for Health offers high-quality dietary supplements and functional foods to healthcare professionals and their patients. Guided by its founding philosophy of “Science First,” the company holds an unwavering commitment to creating research-driven formulations with meaningful quantities of therapeutic ingredients that maximize the potential for successful health outcomes. For nearly 30 years, Designs for Health has been many healthcare professionals’ trusted source for not only product innovation, but also leadership in clinical education and practice development solutions. To learn more, visit https://www.designsforhealth.com or call 800.847.8302.

For media inquiries, please contact Giselle Chollett at giselle@adinnyc.com or 212-693-2152.

Share article on social media or email:

“We are thrilled to be included on the Franchise Times Top 200+ list – a true testament to the hard work and dedication that our franchise owners and national support center team delivers each and every day,” said Jennifer Sheets, Interim HealthCare Inc. CEO and President.

SUNRISE, Fla. (PRWEB)
November 06, 2019

Interim HealthCare Inc., a leading national franchisor of home care, hospice and healthcare staffing, was ranked No. 92 on the Franchise Times 2019 Top 200+ list. This inclusion marks the 17th year Interim HealthCare has been included. Interim HealthCare has also retained its No. 2 rank in the medical and healthcare sector, according to this year’s list.

The 2019 Top 200+ is an annual ranking of the 500 largest franchise systems in the United States by global systemwide sales, based on 2018’s performance. According to Franchise Times, the top 200 largest U.S.-based franchisors grew their combined annual sales by $26.9 billion, or 4.2 percent, in the last year. The health and medical sector was the fastest growing sector on the list, accounting for 14.5 percent of total growth.

“We are thrilled to be included on the Franchise Times Top 200+ list – a true testament to the hard work and dedication that our franchise owners and national support center team delivers each and every day,” said Jennifer Sheets, Interim HealthCare Inc. CEO and President. “We look forward to continuing to deliver the highest quality, most-efficient levels of care in the communities we serve.”

Interim HealthCare offers innovative programs for all franchisees through one of the most experienced franchise support teams in the industry steeped in the complex regulatory environment and components of building a franchise operation, such as marketing, sales, finance, training and human resources. For more details about Interim HealthCare’s franchise opportunities, visit https://www.interimfranchising.com/.

About Interim HealthCare Inc.

Interim HealthCare Inc., founded in 1966, is a leading national franchisor of home care, hospice and healthcare staffing. It is part of Caring Brands International, which also includes UK-based Bluebird Care and Australia-based Just Better Care, both well-known franchise brands in their countries. With more than 530 franchise locations in seven countries, Caring Brands International is a global healthcare leader.

Interim HealthCare in the United States is unique in combining the commitment of local ownership with the support of a national organization that develops innovative programs and quality standards that improve the delivery of service. Franchisees employ nurses, therapists, aides, companions and other healthcare professionals who provide 25 million hours of home care service to 190,000 people each year, meeting a variety of home health, senior care, hospice, palliative care, pediatric care and healthcare staffing needs. For more information or to locate an Interim HealthCare office, visit http://www.interimhealthcare.com.

Share article on social media or email:

www.dicentra.com

“We’re excited to have provided our services to an innovative and sustainable company,” said Dr. Karol Wojewnik, Vice President of Business Development, dicentra.

TORONTO (PRWEB)
November 06, 2019

dicentra, the leading contract research organization (CRO) and global consulting firm for life sciences and food industries, is pleased to announce the successful GRAS status achievement for Comet Bio.

Comet Bio, a manufacturer of healthy and sustainable ingredients, has received GRAS status for its prebiotic dietary fiber Arabinoxylan Plant Fiber Extract. GRAS (Generally Recognized as Safe) is a food ingredient status that meets the standards accepted by the FDA for proper safety and scientific evidence. Arabinoxylan is a naturally occurring dietary fiber found in the cell walls of many plants.

dicentra provided an initial analysis of GRAS requirements, conducted literature searches, evaluated published safety data, prepared independent GRAS conclusions and compiled the self-affirmed GRAS dossier for Comet Bio. dicentra’s expertise was indispensable in demonstrating that Arabinoxylan Plant Fiber Extract is a safe ingredient.

“We’re excited to have provided our services to an innovative and sustainable company,” said Dr. Karol Wojewnik, Vice President of Business Development, dicentra. “Comet Bio has a bold vision for the future of ingredients and dicentra is proud to have contributed to their success.”

“Achieving our Self-Affirmed GRAS status with the help of the dicentra team was an imperative step to certify that our ingredient is safe,” said Rich Troyer, CEO of Comet Bio. “They conducted a thorough review, necessary paperwork submission, and expert research. We couldn’t be happier with the work they have done in order to help us get to this point, and we look forward to continuing our partnership on many other projects.”

To learn more about dicentra, visit http://www.dicentra.com.

About dicentra

dicentra is a contract research organization and professional consulting firm that specializes in addressing all matters related to safety, quality, and compliance for all product categories in the life sciences and food industries. We evaluate, implement, and provide all the necessary support for your products and operations, allowing you to gain market access while building confidence in your brand. We achieve this through our four business divisions: Life Sciences, Food Safety & Quality, Global Certifications, and Clinical Trials. Since our inception in 2002, we have completed over 18,000 projects and serviced over 1,200 companies internationally.

dicentra is headquartered in Toronto, Ontario and has an office in Guelph, Ontario. For more information, visit http://www.dicentra.com.

About Comet Bio

Comet Bio is a manufacturer of award-winning healthy and sustainable ingredients based in London, Ontario and Schaumburg, Ill. The company upcycles crop leftovers into healthy and sustainable ingredients for use in supplements, foods, and beverages. The company’s two flagship products are Sweeterra™ syrup blends and ArrabinaTM Arabinoxylan Plant Fiber Extract that are sustainable and healthy without compromising on taste or performance. Their ingredients are better for the planet because they reduce greenhouse gases and help farmers take advantage of their whole harvest.

For more information, visit http://www.comet-bio.com and follow us on Twitter at @cometbio.

Share article on social media or email:

Asymmetrex Sponsors Podcast on “Counting Stem Cells for a New Era of Medicine”

Dose is essential for stem cell medicine as well.

BOSTON (PRWEB)
November 06, 2019

In October, Massachusetts stem cell biotechnology company Asymmetrex launched a new podcast to provide information to patients about a poorly disclosed deficiency in stem cell treatments. Throughout stem cell medical practice, stem cell treatments are given without knowing the dose of the treating stem cells. This problem affects all patients receiving stem cell treatments, including patients receiving approved treatments in routine clinical practice, patients volunteering for experimental treatments in FDA-authorized clinical trials, and patients obtaining unapproved treatments in private stem cell clinics.

The costs and dangers of unknown stem cell dose in treatments are significant. Stem cell clinical trials cannot be interpreted without knowing the treatment dose, leading to huge wastes of both federal and private clinical research dollars. In the case of manufactured stem cells, many treatments may contain very few or no stem cells at all. It is impossible for doctors to improve treatments without knowing the stem cell dose. Stem cell donors for approved treatments like blood stem cell transplantation are scarce. Knowing the stem cell dose would allow doctors to know when a treatment sample has enough stem cells to treat more than one patient; or when it does not have enough to treat even a single patient. In the second case, not knowing the stem cell dose can result in the death of children treated for leukemia when unknowingly they receive an umbilical cord blood transplant with too few blood stem cells to save them.

Earlier this year, the FDA recognized the pressing need for stem cell dose in stem cell medicine. The agency’s Standards Coordinating Body for Regenerative Medicine (SCB) listed stem cell dose determination as a priority for needed standards for stem cell medicine. Dose is a fundamental principle for the discovery, development, and administration of quality medicines. Asymmetrex Director James L. Sherley, M.D., Ph.D., who is featured in the new podcast, says that, “Dose is essential for stem cell medicine as well. The new podcast has the goal of informing the end users of stem cell treatments: the patients, their doctors, their families, and their advocates, including the FDA. When the people most impacted by these treatments understand that knowing the dose of stem cells is just as important as knowing the dose of their other medicines, they will be empowered to demand this essential certification of the integrity of their stem cell treatments.”

The first episode of the podcast, “Counting Stem Cells For A New Era Of Medicine,” aired online on October 17. The third episode of the biweekly, 6-episode series is scheduled for airing November 12. Each episode features an interview of Asymmetrex Director Sherley by podcast producer Jordan Rich. Mr. Rich guides Dr. Sherley through a discussion of questions that reveal the current challenges that Asymmetrex is addressing to achieve full adoption of stem cell dose as a routine practice in stem cell medicine. The series also highlights other significant applications for stem cell counting in drug development and environmental health science. In conjunction with this educational effort, the company is also sponsoring a study on its website to evaluate the current state of public, academic, and industry knowledge of coming changes in stem cell medicine related to the adoption of stem cell dose.

About Asymmetrex

Asymmetrex, LLC is a Massachusetts life sciences company with a focus on developing technologies to advance stem cell medicine. Asymmetrex’s founder and director, James L. Sherley, M.D., Ph.D. is an internationally recognized expert on the unique properties of adult tissue stem cells. The company’s patent portfolio contains biotechnologies that solve the two main technical problems – production and quantification – that have stood in the way of successful commercialization of human adult tissue stem cells for regenerative medicine and drug development. In addition, the portfolio includes novel technologies for isolating cancer stem cells and producing induced pluripotent stem cells for disease research purposes. Asymmetrex markets the first technology for determination of the dose and quality of tissue stem cell preparations (the “AlphaSTEM Test™”) for use in stem cell transplantation therapies and pre-clinical drug evaluations.

Share article on social media or email:

Dr. Lauren Kopp Celebrates One Year of Providing Restorative Dentistry to Seattle, WA

The patients at this practice have been coming here for 20-30 years. It shows how happy they are and how much they trust us.

Seattle, WA (PRWEB)
November 05, 2019

Dr. Lauren Kopp celebrates one year at LeCuyer & Amato Dentistry, providing state-of-the-art cosmetic and restorative dentistry to Seattle, WA, including porcelain veneers, smile makeovers, dental implants, and the Bioclear Matrix. Receiving her Doctor of Dental Surgery degree from the University of Washington, Dr. Kopp is passionate about serving her Seattle community with empathy and precision in order to give them the best possible results. Highly experienced cosmetic dentists, Drs. Chris LeCuyer and Paul Amato are grateful to have Dr. Kopp on their team.

Admiring the impact that Drs. LeCuyer and Amato have had on Seattle with regards to cosmetic and restorative dentistry treatments, Dr. Kopp is thrilled to be a part of their practice. “I really enjoy the patients that I’ve met here,” says Dr. Kopp. “The patients at this practice have been coming here for 20-30 years. It shows how happy they are and how much they trust us. There is something really nice about having lifelong patients.”

Dr. Kopp values continuing education and has participated in cosmetic and restorative dentistry courses provided by both Invisalign® and the Academy of General Dentistry. Certified in Invisalign and BOTOX®, her favorite aspect of her career is the aesthetic dentistry services she can provide. “It’s pretty rewarding,” Dr. Kopp explains. “The patient can see the difference. It’s a lot of fun having that aesthetic aspect as part of a patient’s treatment.”

In her spare time, Dr. Kopp volunteers with the Medical Teams International Mobile Dental Program. Understanding that untreated dental problems can lead to pain, difficulty eating, and debilitating health conditions, this organization provides free dental care and education to those that need it most. The Mobile Dental Program travels in a bus to bring free cleanings, fillings, and tooth extractions to local churches, community centers, and homeless shelters.

Always at the forefront of technology, LeCuyer & Amato Dentistry offers advanced cosmetic and restorative dentistry to Seattle, WA, including Invisalign, the Bioclear Matrix, dental implants, and porcelain veneers. With porcelain veneers, patients can fully customize their smile through an evaluation stage. During porcelain veneer treatment, the cosmetic dentist prepares the teeth then places provisionals, allowing the patient to evaluate both the aesthetics and function of their new teeth. Once a patient is satisfied, the dentists send the final design to an expert milling lab that will fabricate the permanent restorations.

Individuals looking for cosmetic or restorative dentistry in Seattle, WA, including smile makeovers, Invisalign treatment, and porcelain veneers, are invited to connect with the cosmetic dentists at LeCuyer & Amato Dentistry. To schedule a cosmetic dentistry consultation, call the office at 206-626-5400 or visit their website at http://www.lecuyeramato.com.

About the Dentists

LeCuyer & Amato Dentistry has brought industry leading cosmetic dentistry treatments to Seattle, WA for over 30 years. Dr. Paul Amato is passionate about his community and offers pro bono dental care through organizations like Jewish Family Services and the King County Dental Society. He actively attends continuing education courses to remain on the leading edge of his field, and has advanced training certifications from prestigious institutions including the American Academy of Cosmetic Dentistry and the Kois Center. Dr. Chris LeCuyer has over 30 years of experience in cosmetic dentistry and has lent his expertise to the Academy of General Dentistry and the American Dental Association. Dr. Lauren Kopp received her Doctorate of Dental Surgery from the University of Washington and regularly participates in continuing education courses to gain skills that will improve her patients’ health. These esteemed cosmetic dentists offer the most advanced treatments including the Bioclear Matrix, Invisalign®, and full arch dental implants. The team at LeCuyer & Amato Dentistry is committed to maintaining a standard of excellence in everything they do, providing the highest quality of care and precise results. To learn more about LeCuyer & Amato Dentistry and the industry leading cosmetic dentistry services they offer, visit their website at http://www.lecuyeramato.com, or call the office at 206-626-5400.

Share article on social media or email:

HR inTune brings exciting enhancements to Alera Group’s existing HR service offerings.

DEERFIELD, Ill. and PHILADELPHIA, Pa. (PRWEB)
November 05, 2019

Alera Group, a national employee benefits, property and casualty, risk management and wealth management firm, today announced that it has acquired the business assets of HR inTune, effective October 1, 2019.

HR inTune, located in Berwyn, Pennsylvania, is a human resource consulting firm that helps to address complex workforce management needs through different configurations of HR outsourcing. The firm offers an array of HR services, including compensation program implementation, HR compliance, leadership training, technology analysis and support, and more.

“HR inTune brings exciting enhancements to Alera Group’s existing HR service offerings,” said Alan Levitz, CEO of Alera Group. “We are thrilled to welcome the HR inTune team, led by Jamie Honigman, and we look forward to the many ways future collaboration will positively impact our clients.”

“Becoming part of Alera Group is a powerful next step for our firm,” said Jamie Honigman, President of HR inTune. “With the national resources of Alera Group, we are positioned for growth through collaboration, elevating our clients’ experience as we offer more resources and tools than ever before.”

HR inTune joins Alera Group through their Philadelphia location. The HR inTune service team will continue serving clients in their current roles. Terms of the transaction were not disclosed.

About Alera Group

Based in Deerfield, IL, Alera Group’s over 1,800 employees serve thousands of clients nationally in employee benefits, property and casualty, risk management and wealth management. Alera Group is one of the 20 largest independent insurance agencies in the country. For more information, visit http://www.aleragroup.com or follow Alera Group on Twitter: @AleraGroupUS

Share article on social media or email:

symplr engage Regional User Conference

Planning for the 2020 regional user conferences is underway. We can’t wait to reveal the dates and locations soon.

HOUSTON (PRWEB)
November 05, 2019

symplr®, a leading healthcare governance, risk management and compliance (GRC) software as a service (SaaS) platform, today announced that the final symplr engage™ Regional User Conference of 2019 will be held in Nashville, December 12-13, 2019, at the DoubleTree by Hilton Hotel Nashville Downtown. Customers can attend this free, two-day event featuring more than 30 sessions hosted by the provider management industry’s best and brightest educators.

“The engage user conference is a win-win for both the symplr team, who has the pleasure of meeting many of our customers in-person, and for our customers who get face-to-face time with symplr experts, free NAMSS CEUs, and are the first to learn what’s new with their symplr solutions,” said Amie Teske, Vice President and General Manager, Provider Management at symplr. “Planning for the 2020 regional user conferences is underway. We can’t wait to reveal the dates and locations soon.”

This year, attendees can select from more than 30 session topics such as “FPPE Refresh,” “What’s New in the Cactus Provider Management Platform,” “Documenting Provider Competency for Low and No Volume Practitioners,” and more. Registration has been simplified, allowing attendees to both pre-select sessions and register multiple team members at once. Check out the complete agenda.

Registration for the two-day conference is free to symplr clients and $500 for non-clients. To learn more and register, visit https://www.symplr.com/engage2019

About symplr

Founded in 2006, symplr is an industry leader in governance, risk management and compliance SaaS solutions that help healthcare organizations mitigate risk and ensure compliance. symplr has a single mission: to make healthcare GRC simpler for all constituents of the healthcare community. More information is available at http://www.symplr.com.

Share article on social media or email: